ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

11040	Companies
241967	Keywords
170396	Articles
130283	Press releases

Home
Companies
ABIVAX

BRIEF

published on 04/02/2024 at 08:35, 2 years 5 months ago

Abivax publie ses résultats financiers 2023 et un point opérationnel

Résultats Financiers Abivax Obefazimod Rectocolite Hémorragique Introduction En Bourse Au Nasdaq
PRESS RELEASE

published on 04/02/2024 at 08:30, 2 years 5 months ago

Abivax reports 2023 financial results and operational update
Abivax reports 2023 financial results & operational update. Raised EUR 500M, aims to finance operations till Q4 2025. Webcast on April 8, 2024

Financial Results Fundraising Abivax Webcast Operational Update
PRESS RELEASE

published on 04/02/2024 at 08:30, 2 years 5 months ago

Abivax publie ses résultats annuels 2023 et présente un point d’avancement sur l’activité
Abivax publie ses résultats annuels 2023 et présente un point d'avancement sur l'activité, démontrant une forte croissance financière et des progrès dans ses programmes cliniques

Croissance Financement Abivax Résultats Annuels 2023 Programmes Cliniques
BRIEF

published on 03/27/2024 at 18:05, 2 years 5 months ago

ABIVAX publie son nombre d’actions et de droits de vote au 29 février 2024

Euronext Paris Droits De Vote Capital Social Abivax Réglementation
BRIEF

published on 03/27/2024 at 18:05, 2 years 5 months ago

ABIVAX publishes its number of shares and voting rights as of February 29, 2024

Euronext Paris Share Capital Voting Rights Abivax Regulation
PRESS RELEASE

published on 03/27/2024 at 18:00, 2 years 5 months ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 29.02.24.
ABIVAX communique le nombre d'actions et de droits de vote au 29/02/2024, conformément aux règlements financiers. Abivax est une société de biotechnologie en phase clinique axée sur le développement de traitements thérapeutiques

Droits De Vote Biotechnologie Actions Abivax Traitements Thérapeutiques
BRIEF

published on 02/23/2024 at 18:00, 2 years 6 months ago

ABIVAX annonce une mise à jour sur son capital social et ses droits de vote

Droits De Vote Capital Social Biotechnologie Abivax Transparence Financière
BRIEF

published on 02/23/2024 at 18:00, 2 years 6 months ago

ABIVAX announces an update on its share capital and voting rights

Share Capital Voting Rights Biotechnology Abivax Financial Transparency
PRESS RELEASE

published on 02/23/2024 at 18:00, 2 years 6 months ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.24.
ABIVAX communique le nombre d'actions et de droits de vote au 31 janvier 2024. Abivax est une société de biotechnologie développant des traitements pour les maladies inflammatoires

Droits De Vote Biotechnologie Actions Abivax Maladies Inflammatoires
PRESS RELEASE

published on 02/13/2024 at 08:30, 2 years 7 months ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)
Abivax to present four abstracts on obefazimod for ulcerative colitis at 19th ECCO Congress, including a sponsored symposium on emerging treatment mechanisms. Event details available on ECCO website

Abivax Obefazimod Ulcerative Colitis ECCO Congress Scientific Symposium

Accesswire

Published on 09/22/2026 at 00:00, 5 hours 57 minutes ago

Alset AI Announces Shares for Debt Transaction
Published on 09/21/2026 at 15:45, 14 hours 12 minutes ago

Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 15 hours 37 minutes ago

Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 15 hours 52 minutes ago

Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 15 hours 57 minutes ago

Dateline Files Motion to Resume Operations at Colosseum

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 01:05, 4 hours 51 minutes ago

ESENTIA Announces the Execution of an Agreement to Acquire the Guadalajara-Manzanillo Natural Gas Pipeline System, Connecting Existing System to the Port of Manzanillo
Published on 09/21/2026 at 22:05, 7 hours 52 minutes ago

Abivax Presents Business Updates and First Half 2026 Financial Results
Published on 09/21/2026 at 22:05, 7 hours 52 minutes ago

Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
Published on 09/21/2026 at 20:34, 9 hours 22 minutes ago

BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 19:00, 10 hours 57 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 14 septembre 2026 au 18 septembre 2026

Les Echos

Published on 09/21/2026 at 18:19, 11 hours 38 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 11 hours 38 minutes ago

Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 11 hours 55 minutes ago

Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 12 hours 11 minutes ago

WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 12 hours 11 minutes ago

WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026

View all LES ECHOS COMFI WIRE